Plan: OPEN | Option: Dividend | Sailesh Raj Bhan

18 Sep 19 | 12:00 AM

48.67 0.21 (0.43%)

  • Outperforms


    Return (1Y)

    beaten by 3.42%

  • Less Volatile


    Standard Deviation (1Y)

    Lower than by -0.43%

  • Consistent



    Has beaten

  • Value research rating

    Not Rated

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.


In last 1 year Reliance Pharma Fund (D), has beaten its benchmark, by 3.42% (CAGR difference)



This is +ve Alpha

Performance Chart for Rs

Invested in


In last 1 year , the volatility of Reliance Pharma Fund (D),is Lower than its benchmark, by -0.43%


Less Volatile

Risk Meter

Peer Comparison on Risk - Return


For 7 out of Last 12 Months, i.e 58.33% of the times It has beaten its benchmark,

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, 4 Stocks beating the benchmark 14 Stocks not beating the benchmark

View Stock Composition